NCT04939584 is a NA clinical trial of MultiPulse Therapy in Atrial Fibrillation, sponsored by Cardialen, Inc..

Who is sponsoring NCT04939584?

NCT04939584 is sponsored by Cardialen, Inc..

What drugs are being tested in NCT04939584?

Interventions in NCT04939584: MultiPulse Therapy.

What condition does NCT04939584 study?

NCT04939584 studies Atrial Fibrillation.

Is NCT04939584 still recruiting?

NCT04939584 is currently terminated. Last updated 10 October 2022.

Last reviewed 2022-10-10 · How we verify

NCT04939584

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Perception of MultiPulse Therapy™ (MPT™)

Terminated NA Last updated 10 October 2022

What this trial tests

NA trial testing MultiPulse Therapy in Atrial Fibrillation in 6 participants. Terminated before completion.

Timeline

19 November 2021

Primary endpoint
1 October 2022

1 October 2022

Quick facts

Lead sponsor	Cardialen, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	6
Start date	19 November 2021
Primary completion	1 October 2022
Estimated completion	1 October 2022
Sites	2 locations across Australia

Drugs / interventions tested

MultiPulse Therapy

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Cardialen, Inc.

Who can join

Adults 18 to 80, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assess the subject acceptance of MPT, using therapy parameters that have been shown to be effective in terminating episodes of atrial fibrillation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Cardialen, Inc. trials

Trials by the same sponsor.

NCT05055921 — MultiPulse Therapy (MPT) for AF (US) · NA · terminated
NCT04206917 — MultiPulse Therapy (MPT) for AF · NA · terminated
NCT03871231 — Unpinning Termination Therapy for VT/VF · NA · terminated
NCT03093051 — Unpinning Termination Therapy for VT (US) · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04939584 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cardialen, Inc.
Last refreshed: 10 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04939584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing